A detailed history of West End Advisors, LLC transactions in Bio Techne Corp stock. As of the latest transaction made, West End Advisors, LLC holds 2 shares of TECH stock, worth $142. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2
Previous 2 -0.0%
Holding current value
$142
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 29, 2024

SELL
$62.12 - $84.15 $62 - $84
-1 Reduced 33.33%
2 $0
Q1 2024

May 07, 2024

BUY
$65.98 - $77.09 $65 - $77
1 Added 50.0%
3 $0
Q3 2023

Oct 19, 2023

BUY
$67.52 - $89.42 $135 - $178
2 New
2 $0
Q1 2023

Apr 28, 2023

SELL
$71.62 - $86.62 $143 - $173
-2 Reduced 50.0%
2 $0
Q4 2022

Jan 31, 2023

BUY
$80.67 - $352.29 $242 - $1,056
3 Added 300.0%
4 $0
Q3 2022

Oct 27, 2022

BUY
$282.54 - $391.85 $282 - $391
1 New
1 $0

Others Institutions Holding TECH

About BIO-TECHNE Corp


  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $2.8B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track This Portfolio

Track West End Advisors, LLC Portfolio

Follow West End Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of West End Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on West End Advisors, LLC with notifications on news.